The recycling mannose lectin ERGIC-53 operates as a transport receptor by mediating efficient ER export of some secretory glycoproteins. Binding of cargo to ERGIC-53 in the ER requires Ca 2+ . Cargo release occurs in the ERGIC, but the molecular mechanism is unknown. Here we report efficient binding of purified ERGIC-53 to immobilized mannose at pH 7.4 -the pH of the ER -but not at slightly lower pH. pH-sensitivity of the lectin was more prominent when Ca 2+ concentrations were low. A conserved histidine in the center of the carbohydrate recognition domain was required for lectin activity suggesting it may serve as a molecular pH/Ca 2+ sensor. Acidification of cells inhibited ERGIC-53's association with the known cargo cathepsin Z-related protein and dissociation of this glycoprotein in the ERGIC was impaired by organelle neutralization which did not impair the transport of a control protein. The results elucidate the molecular mechanism underlying reversible lectin/cargo interaction and establish the ERGIC as the earliest low pH-site of the secretory pathway.
Introduction
After translocation into the ER, soluble secretory proteins -here termed cargo proteins -start their journey along the organelles of the secretory pathway. This process requires correct folding and ongoing sorting from resident proteins of the compartments through which they move. The first such separation occurs during transport from the ER to the Golgi apparatus. The molecular nature of this sorting event has been extensively studied and led to two models that may coexist and each apply for a distinct subset of cargo proteins (1) The type I transmembrane protein ERGIC-53 is ubiquitously expressed and constitutively cycles between ER and ER-Golgi intermediate compartment (ERGIC) 1 (5) . In the ERGIC the protein segregates from anterograde-directed protein traffic and returns to the ER largely bypassing the Golgi appartus (6) . ERGIC-53 is a lectin. In its luminal part it carries a carbohydrate recognition domain (CRD) with a ß-sandwich fold (7) that shares significant sequence similarity and many structural details with the carbohydrate binding sites of plant L-type lectins (8) (9) (10) . It preferentially binds to D-mannose (11) and recognizes protein-linked high-mannose type oligosaccharides in vivo (2) . The lack of functional ERGIC-53 leads to inefficient secretion of the glycoproteins cathepsin C (12) and blood coagulation factors V and VIII (13) .
Crosslinking studies have established a cathepsin Z-related protein (catZr) as a model glycoprotein cargo for ERGIC-53 and documented that cargo capture starts in the ER and cargo release occurs in the ERGIC (2) . Although such a differential binding of the transport receptor to its cargo is fundamental, the molecular nature of this process has remained elusive. Based on the finding that lectin activity of ERGIC-53 strictly depends on Ca 2+ (2,11), we have speculated earlier that a drop of calcium levels along the ERto-ERGIC pathway may trigger glycoprotein dissociation (5) . Indeed, an imaging approach that measures total Ca 2+ in ultrathin cryosections revealed positive signals for both ER and Golgi, but ERGIC elements remained below detection level (14) .
Nevertheless, calcium deprivation as the sole determinant for cargo release appears unlikely, as the concentration gradient of free Ca 2+ from ER to ERGIC may be subtle.
Apart from that, a pH-driven sorting mechanism -in analogy to the endosomal systemhas been suggested based on in vitro studies (15, 16) . Organellar pH is determined by the presence of active H + v-ATPase pumps -a 10 6 kDa complex consisting of 13 polypeptides -and of opposed H + leak rates (17) . While the progressive acidification from the ER (pH 7.1 -7.4) to the trans-Golgi network (pH 5.9 -6.3) has been established, it is still largely questioned, however, if significant proton pumping and organelle acidification occurs already in the early secretory pathway, i.e. the ERGIC/cisGolgi region (for review see: (18) ). The evidence is rather sketchy and includes the observations that the v-ATPase proteolipid subunit co-fractionates with ERGIC membranes, the v-ATPase inhibitor bafilomycin A1 exhibits a cell-type specific Golgito-ER retrograde transport defect, and there is minor overlap of DAMP staining with ERGIC-53 (19, 20) . The notion of pre-Golgi acidification is far from being established and requires further evidence to be proven.
By studying the lectin properties of ERGIC-53 in more detail, we report here that low pH modulates ERGIC-53's activity in vitro and in vivo. The data suggest a molecular scenario underlying reversible lectin inactivation that involves protonation of a conserved histidine sensor residue and loss of Ca 2+ . In conjunction with our previous studies, the results establish the ERGIC as the earliest acid compartment of the secretory pathway.
Experimental procedures

Reagents
The following antibodies were used: mAb 9E10. 
Cell culture, transfections, drug treatment, and in situ crosslinking
COS-1 cells were grown in DMEM supplemented with 10 % fetal bovine serum, 100
I.U. ml -1 penicillin, 100 µg ml -1 streptomycin, and 1 µg ml -1 amphotericin B (Sigma).
Cells were transfected using the DEAE-Dextran method ((23); 10 µg DNA/ 10 cm dish).
CHO-KI cells and lec1-derived stable clones (GM or GMAA, (24)) were grown in ±-MEM supplemented with 10 % fetal bovine serum, 100 I.U. ml -1 penicillin, 100 µg ml -1 streptomycin, and 1 µg ml -1 amphotericin B. Chloroquine (100 µM) was added 1 h before metabolic labeling and was present throughout the pulse-chase period. 
Pulse-chase experiments, immunoprecipitation, and endoglycosidase digest
Cells were labeled with 35 S-methionine, chased in DMEM containing 10 mM unlabeled methionine, and subjected to immunoprecipitation (26) using mAb G1/93 or pAb against fibronectin and protein A-Sepharose (Amersham). Immunoprecipitation of intracellular catZr was performed after antigen denaturation at 95°C in 30 mM triethanoamine/HCl pH 8.1, 100 mM NaCl, 5 mM EDTA containing 1.6 % SDS followed by addition of an excess of TX-100 (2% final concentration) in the same buffer. Secreted catZr was methanol-chloroform precipitated (27) and then subjected to the same procedure. Where indicated, cells were treated with DSP prior to solubilization, or immunoprecipitates were digested with endoD or endoH as previously descibed (24) . Gels were analyzed and quantified on a STORM 820 Phosphorimager (Amersham) or by fluorography. 
Immunofluorescence microscopy
GM-
Results
Lectin activity of ERGIC-53 is modulated by pH and Ca 2+
To gain insight into the molecular mechanism of ERGIC-53/cargo interaction, we designed an in vitro lectin assay. Full-length oligomeric ERGIC-53 carrying a Nterminal myc-epitope and a 6xHis-tag at the C-terminus (myc/6xHis, (11) Fig. 1 B) , indicating specificity.
This assay was used to further study the lectin properties of ERGIC-53. First, we tested the possibility that mannose binding was sensitive to acid. To this end, binding experiments were performed in buffers of pH 7.4 -corresponding to the pH of the ER (18) -down to pH 6.0. Fig. 1 C shows that the fraction of active ERGIC-53 was gradually reduced to 13 ± 6 % at pH 6.0. Inactivation by pH 6.0 treatment could be readily reversed by neutralization ( Fig. 1 D) . Interestingly, the sensitivity of the lectin to low pH was linked to Ca 2+ as it was completely suppressed if [Ca 2+ ] was raised to 5 mM ( Fig. 2 A) . In a next set of experiments the binding of ERGIC-53 was assayed at constant pH over a range of [Ca 2+ ] (Fig. 2 B) . Half maximal binding was observed in the presence of 150 µM Ca 2+ at pH 7.4, 230 µM Ca 2+ at pH 6.5 and 800 µM Ca 2+ at pH 6.0. We conclude that pH-sensitivity of ERGIC-53 is at least in part due to pH-induced changes in Ca 2+ -affinity raising the possibility that pH-sensing and Ca 2+ complexation may be mediated by the same amino acid(s).
Histidine178 has the hallmarks of a molecular pH-sensor
In search of the molecular mechanism underlying acid sensitivity we scanned the CRD of ERGIC-53 for potentially titratable residues. Histidine (His) is the only basic amino acid that can be considerably protonated in moderately acidic solutions as used above. His178 is both conserved in ERGIC-53 orthologs and positioned in a characteristic ±-helix in binding or -more likely -Ca 2+ -complexation (see Fig. 2 
ERGIC-53/glycoprotein association is sensitive to acidic pH
Does the binding of ERGIC-53 to a known glycoprotein ligand also depend on neutral pH? We studied intracellular binding of catZr to ERGIC-53 by in situ crosslinking (2) in cells that were subjected to a pH-clamp procedure. pH-clamping adapts all cellular compartments to the pH of the applied buffer, irrespective of organelle specific ion concentrations and permeabilities (25) . Because this procedure perturbs transport along the biosynthetic pathway (our unpublished observations, (18)), we made use of GMAA cells that stably express a transport-impaired ERGIC-53 mutant that is restricted to the ER (24), but still efficiently crosslinks to catZr by Dithiobis(succinimidylpropionate) (DSP) (2) . This crosslinker covalently links the two proteins and after reductive cleavage slightly increases their apparent molecular mass. We chose to assess the effect of pH 6.5-and pH 6.0-treatment in relation to neutral pH taking into account pK a (His) of ~6.5.
Since (2) crosslinked to GMAA-ERGIC-53 on the other hand was significantly reduced with decreasing pH (Fig. 4, lanes 2-4, catZr) . During the crosslinking procedure at neutral pH some reassociation may occur, but this process seems to be slow at 4°C in the viscous environment of the ER lumen. Consistent with this, binding of catZr to ERGIC-53 after acidic pH-clamping was only partially restored if crosslinking was performed in the presence of chloroquine (Fig. 4 , lanes 5-7, catZr). Since pH-induced misfolding of catZr, a predicted lysosomal enzyme, is unlikely, we conclude that an artificially applied acidic pH in the lumen of the ER drives dissociation of catZr from ERGIC-53.
Neutralization of the ERGIC inhibits cargo release
We wondered if pH-driven glycoprotein dissociation from ERGIC-53 also occurs in living cells without acidic manipulation. Our previous studies have localized the site of catZr cargo release from ERGIC-53 to the ERGIC (2). If indeed an endogenous acidification mechanism of the ERGIC is the driving force for the dissociation, we expect that neutralization of the intra-organellar pH would delay this process. We chose to use the dibasic compound chloroquine that elevates the pH within acidic organelles by a weak base mechanism at micromolar concentrations (minimizing osmotic swelling) and by the lack of primary amino groups does not interfere with DSP-crosslinking (see above).
To verify that such organelle neutralization does not generally affect membrane traffic in the early secretory pathway, which would lead to mis-interpretations, we assayed the recycling of ERGIC-53 by two different methods. First, pulse-chase experiments were performed in the presence or absence of 100 µM chloroquine using CHO-KI derived GM-Lec1 cells (24) , and immunoprecipitated ERGIC-53 was probed for sensitivity to endoglycosidase D (endoD). Lec1 cells lack the Golgi enzyme Nacetylglucosamine transferase I, and as a consequence N-glycosylated proteins, upon passage through the cis-Golgi, become and remain endoD-sensitive by the action of Golgi mannosidase I. As the major recycling route of ERGIC-53 largely bypasses the cis-Golgi (6), the acquisition of endoD-sensitivity is a slow process (24) and an exact measure of ERGIC-53 trafficking. After crosslinking the amount of catZr co-immunoprecipitated with anti-ERGIC-53 was analyzed. Chloroquine indeed delayed the release of catZr (Fig. 6 A) . We reasoned that this observation could reflect (i) enhanced crosslinking in the presence of chloroquine,
(ii) an unspecific block in secretion that would slow down transport of catZr at the level of ER-exit, possibly followed by its degradation or (iii) impaired dissociation from ERGIC-53 in the ERGIC. An effect of chloroquine on the efficiency of DSP-treatment can be excluded (Fig. 4 and 30 min chase in Fig. 6 A) . To test the second possibility we performed a pulse-chase analysis in GM-lec1 cells with an antiserum that specifically recognizes catZr (our unpublished observations). As shown in Fig. 6 B, in untreated cells, catZr gradually converted from the proform to the mature enzyme indicating its targeting to the lysosomal pathway. In contrast, upon treatment with chloroquine, catZr remained unprocessed and the proform persisted slightly longer which is consistent with its slower transit through the early secretory pathway. Furthermore, we analyzed the appearance of the metabolically labeled, unprocessed catZr-proenzyme in the culture medium from chloroquine-treated or control cells. Regardless of neutralization the cells secreted catZr (Fig. 6 C) . In chloroquine-treated cells the inhibition of intracellular maturation (Fig. 6 B), that may arise from the impaired function of acid hydrolases and/or from transport defects, caused hypersecretion of catZr, a phenomenon known for lysosomal proteins.
This renders it impossible to quantitatively compare the rate of secretion with or without neutralization and most likely accounts for the seeming paradox of retention in the ERGIC versus enhanced secretion of catZr. Collectively, these findings demonstrate that chloroquine neither initiates the degradation nor blocks the secretion of catZr, but causes some setback in its early transport through the secretory pathway. To discriminate whether under these conditions secretory transport is generally affected or if this delay is specific for catZr, we sought to measure the transport of an independent secretory marker.
To this end, we examined glycosylation modifications on fibronectin, a ubiquitous component of the extracellular matrix. Because we failed to detect the accumulation of endoD-sensitive fibronectin in GM-lec1 cells (data not shown), we used endoglycosidase H (endoH) and wt CHO-KI cells. Contrary to lec1 cells, fibronectin secreted from this cell line was resistant to endoH as expected (data not shown). To study ER to medial-Golgi transport of fibronectin we performed pulse-chase/endoH experiments and assessed the acquisition of endoH-resistance. Fig. 6 D shows that intracellular fibronectin was readily lost with or without chloroquine and that this drug did not slow down fibronectin trafficking from the ER to the medial-Golgi. We conclude that chloroquine treatment specifically retards the dissociation of catZr from ERGIC-53
indicating that pH-induced conversion of the lectin domain of ERGIC-53 in the ERGIC contributes to efficient release of its glycoprotein cargo.
Discussion
In this study we have uncovered the molecular mechanism of reversible lectin binding of ERGIC-53 to its substrates. Subtle pH-changes inactivate and reactivate ERGIC-53's CRD in vitro and in vivo. We propose a model for cargo release by pH-induced loss of Ca 2+ (Fig. 7) . Ca 2+ -complexed ERGIC-53 binds cargo in the ER at neutral pH. Upon arrival in the ERGIC, His178 is protonated due to lowered luminal pH and Ca 2+ is lost.
Because Ca 2+ is required for the lectin activity of ERGIC-53 ((2,11); this study), its loss leads to the inactivation of the mannose-binding pocket resulting in the release of glycoprotein cargo. Subsequently, the transport receptor is recycled back to the ER, where -with a deprotonated and reactivated CRD -it can start a new round of cargo capture. Interestingly, a similar mechanism has been reported for C-type lectins, such as asialoglycoprotein receptor, and their glycoprotein cargo upon endocytosis from the plasma membrane (29, 30) . In that case, however, the acidification ranges from extracellular pH 7.3 to endosomal pH 5.4 and, as a consequence, pH sensing by the asialoglycoprotein receptor can be achieved by a cluster of amino acids that includes an aspartic acid and an arginine residue (31) . It is important to note that the [Ca 2+ ]-range we found to allow pH-sensitive mannose binding of ERGIC-53 (Fig. 2 B) (Fig. 6 A) .
Although high concentrations of free Ca 2+ have been measured within both the ER (~400 µM) and the Golgi (~300 µM) (32-34), we are still lacking quantitative records of [Ca 2+ ] ERGIC . The in vivo demonstration of differential Ca 2+ -regulation along the secretory pathway will be one of our challenges in the future.
The presented model implies a molecular link between pH-sensing and Ca 2+
complexation. Indeed, our in vitro mannose binding studies indicated a modulation in ERGIC-53's affinity to Ca 2+ ions in a slightly acidified environment (Fig. 2 B) .
Furthermore, we identified His178 to be essential for lectin activity, presumably in its deprotonated state. Glutamine cannot mimick the function of His178 suggesting that this amino acid may be part of a precise ligand binding pocket. These findings led us to
propose that the pH-sensor residue His178 -directly or indirectly -is involved in Ca 2+
binding, and that its protonation would trigger loss of the cation by a repulsive interaction (Fig. 7 ). Whether such a mechanism would involve one or more Ca 2+ ions is not known.
It is worth noting that the closely related lectin Vip36 has been shown to bind two Ca 2+
ions (35) . Co-crystallization of ERGIC-53 with Ca 2+ and a sugar ligand will help to address this issue and verify our prediction. In the calcium-free crystal structure of ERGIC-53 (7) His178 is located in an ±-helical loop next to the mannose binding site that we termed the Histidine Ion Sensor (HIS)-loop. It must be emphasized that in the crystal notably the central metal/sugar binding loop C (36) was disordered in the absence of Ca 2+ (7). Hence, the structure presented in fig. 3 transport of Golgi mannosidase II that seems to be highly cell type-specific (18) . In the light of our quantitative recycling studies in the presence of chloroquine (Fig. 5 A) ,
however, it appears likely that these observations were not a result of organelle neutralization but rather due to other effects caused by bafilomycin A1 treatment (18) .
Although the staining pattern of ERGIC-53 showed some minor overlap with acidic compartments that were trapped (and neutralized) with the weak base DAMP, consistent with our chloroquine experiments (Fig. 5 B) , no tubulation phenotype was seen in these cells and the obvious negative control using bafilomycin A1 was omitted (20) . Other suggestions in the literature for an acidification mechanism of the ERGIC or early Golgi were deduced from pH-dependent in vitro processes such as the binding of ADPribosylation factor to microsomes (38) , the dissociation of RAP from LDL receptorrelated protein (15) , and the binding of KDEL-peptides to KDEL receptor (16) . None of these pH-dependencies, however, could be (i) demonstrated in situ or (ii) attributed to the action of titratable sensor amino acids. Finally, a proteolytic pre-Golgi event that remained unclassified appeared to depend on organelle acidification (39, 40) . The data presented here, however, combine the in vitro characterization of a pH-driven molecular mechanism with the documentation of its in vivo relevance and thus, to our knowledge, add the highest level of evidence for pre-Golgi acidification. As targeting of a pH-probe (25, 41) exclusively to the ERGIC is impossible due to the lack of a marker protein that does not recycle through the ER, a reliable measurement of pH ERGIC has never been reported and may hardly be expected. Even so, the conclusions presented herein are of particular biomedical interest given the fact that multiple diseases including cystic fibrosis (42) and Alzheimer's disease (43) have been associated with molecular processes in the ERGIC.
Loss of ERGIC-53 expression in humans causes combined deficiency of coagulation factors V and VIII (13) . A recent study has revealed a second protein implicated in this disease, MCFD2, an EF-hand protein that co-purifies with ERGIC-53 in a Ca 2+ -dependent way (44) . Our data show that ERGIC-53 purified in the absence of 
